Cindy Jacobs
2013
In 2013, Cindy Jacobs earned a total compensation of $1M as Executive Vice President and Chief Medical Officer at OncoGenex Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $120,942 |
|---|---|
| Option Awards | $172,835 |
| Salary | $403,142 |
| Stock Awards | $338,783 |
| Total | $1,035,702 |
Jacobs received $403.1K in salary, accounting for 39% of the total pay in 2013.
Jacobs also received $120.9K in non-equity incentive plan, $172.8K in option awards and $338.8K in stock awards.
Rankings
In 2013, Cindy Jacobs' compensation ranked 6,439th out of 12,286 executives tracked by ExecPay. In other words, Jacobs earned more than 47.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,439 out of 12,286 | 48th |
Division Manufacturing | 2,261 out of 4,612 | 51st |
Major group Chemicals And Allied Products | 674 out of 1,462 | 54th |
Industry group Drugs | 489 out of 1,156 | 58th |
Industry In Vitro and In Vivo Diagnostic Substances | 23 out of 56 | 59th |
Source: SEC filing on April 24, 2014.
Jacobs' colleagues
We found three more compensation records of executives who worked with Cindy Jacobs at OncoGenex Pharmaceuticals in 2013.
News
OncoGenex Pharmaceuticals CEO John Bencich's 2022 pay slips 7% to $1.5M
April 28, 2023
OncoGenex Pharmaceuticals CEO John Bencich's 2021 pay jumps 82% to $1.6M
April 21, 2022
OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
March 30, 2021
OncoGenex Pharmaceuticals CEO Richard Stewart's 2019 pay falls 27% to $797K
April 2, 2020
OncoGenex Pharmaceuticals CEO Richard Stewart's 2018 pay jumps 423% to $1.1M
March 28, 2019